On Thursday, Dynavax Technologies Corporation announced that the U.S. Food and Drug Administration (FDA) approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection...

Last week, to coincide with World Hepatitis Day, a new report, commissioned by United European Gastroenterology (UEG), calls for all European countries to adopt universal vaccination and harmonized screening...

In a follow-up to a report from 2012, the European Medicines Agency’s Committee for Medicinal Products for Human Use(CHMP) has adopted a positive scientific opinion for Mosquirix (Plasmodium falciparum and...

Millions of Americans are living with chronic viral hepatitis, and many do not know they are infected. Every year, approximately 15,000 Americans die from liver cancer or chronic liver disease associated...

A study to determine whether vaccines, particularly those for hepatitis B (HepB) and human papillomavirus (HPV), increased the risk of multiple sclerosis (MS) or other acquired central nervous system demyelinating...